| Document And Entity Information | Nov. 12, 2024 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Nov. 12, 2024 |
| Entity Registrant Name | Arcadia Biosciences, Inc. |
| Entity Central Index Key | 0001469443 |
| Entity Emerging Growth Company | false |
| Entity File Number | 001-37383 |
| Entity Incorporation, State or Country Code | DE |
| Entity Tax Identification Number | 81-0571538 |
| Entity Address, Address Line One | 5950 Sherry Lane |
| Entity Address, Address Line Two | Suite 215 |
| Entity Address, City or Town | Dallas |
| Entity Address, State or Province | TX |
| Entity Address, Postal Zip Code | 75225 |
| City Area Code | 214 |
| Local Phone Number | 974-8921 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common |
| Trading Symbol | RKDA |
| Security Exchange Name | NASDAQ |
